SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.03 CNY | +6.47% |
|
+17.09% | -5.97% |
Chart calendar Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
547b8d53e5ce49344ab5b464c4541.3PjYvXkcDGvzkwAKSajiJhhFyPMvy6hfCIOgURcrps8.hIrv5UBeaF-h3W5uC8Cwdip3-Lp3uf85bsHxGHFe3vi7kL7zISVLIabdWQ~928a2b6ba51db29a7ac000298cf725a7
Upcoming events on Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
Past events on Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
| 29/04/2024 | Q1 2024 Earnings Release |
| 28/03/2024 | Q4 2023 Earnings Release |
| 10/01/2024 11:30 am | Extraordinary Shareholders Meeting |
| 15/12/2023 11:30 am | Extraordinary Shareholders Meeting |
| 30/10/2023 | Q3 2023 Earnings Release |
| 30/08/2023 | Q2 2023 Earnings Release |
| 22/05/2023 11:30 am | Annual General Meeting |
| 28/04/2023 | Q1 2023 Earnings Release |
| 30/03/2023 | Q4 2022 Earnings Release |
| 04/11/2022 12:00 pm | Extraordinary Shareholders Meeting |
| 28/10/2022 | Q3 2022 Earnings Release |
| 29/08/2022 | Interim 2022 Earnings Release |
| 10/06/2022 12:00 pm | Annual General Meeting |
| 29/04/2022 | Q1 2022 Earnings Release |
| 11/04/2022 | FY 2021 Earnings Release |
| 04/01/2022 | Extraordinary Shareholders Meeting |
| 28/10/2021 | Q3 2021 Earnings Release |
| 28/09/2021 12:00 pm | Extraordinary Shareholders Meeting |
| 27/08/2021 | Interim 2021 Earnings Release |
| 26/05/2021 12:00 pm | Annual General Meeting |
Past dividends on Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
| 18/07/2023 | Annual 0.1 CNY |
| 28/07/2022 | Annual 0.035 CNY |
| 06/07/2021 | Annual 0.15 CNY |
| 01/07/2020 | Annual 0.18 CNY |
| 15/07/2019 | Annual 0.1 CNY |
| 02/07/2018 | Annual 0.045 CNY |
| 28/06/2017 | Annual 0.25 CNY |
| 13/06/2016 | Annual 0.6 CNY |
| 09/06/2015 | 0.3 CNY |
| 09/06/2014 | Annual 0.3 CNY |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million CNY | Released Forecast Spread | 4 625 5 521 -16.24% | 5 332 5 755 -7.35% | 6 365 6 323 0.66% | 7 159 7 354 -2.64% | 5 446 5 528 -1.5% | 5 816 |
|
EBITDA Million CNY | Released Forecast Spread | 0,00 0,00 - | 1 607 1 480 8.56% | 502 1 315 -61.82% | 1 387 1 353 2.58% | -510 834 -161.12% | 982 |
|
EBIT Million CNY | Released Forecast Spread | 1 315 889 47.89% | 1 330 1 206 10.26% | 926 1 046 -11.42% | 829 1 107 -25.14% | -861 617 -239.54% | 752 |
|
Earnings before Tax (EBT) Million CNY | Released Forecast Spread | 1 315 948 38.71% | 1 328 1 100 20.71% | 222 1 037 -78.57% | 830 1 095 -24.21% | -928 277 -434.58% | 570 |
|
Net income Million CNY | Released Forecast Spread | 1 059 898 17.97% | 1 024 913 12.19% | 241 810 -70.27% | 727 990 -26.53% | -783 199 -494.14% | 473 |
|
EPS CNY | Released Forecast Spread | 0,85 0,72 17.97% | 0,76 0,62 22.06% | 0,16 0,55 -70.16% | 0,50 0,67 -26.04% | -0,53 0,36 -248.28% | 0,44 |
| Announcement Date | 28/02/20 | 29/03/21 | 30/03/22 | 29/03/23 | 28/03/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million CNY | Released Forecast Spread | 1 910 1 507 26.79% | 1 846 1 898 -2.74% | 1 637 1 855 -11.76% | 1 756 1 787 -1.73% | 1 301 1 644 -20.84% | 1 405 2 009 -30.05% | 1 350 1 478 -8.64% | 1 368 1 495 -8.5% | 1 368 | 1 387 | 1 407 | 1 531 |
|
EBIT Million CNY | Released Forecast Spread | 283 224 26.63% | 259 | 212 345 -38.48% | 234 215 8.62% | 73,6 205 -64.09% | 294 | 137 | 135 | 252 | 105 | 202 | 179 |
| Announcement Date | 29/04/22 | 29/08/22 | 28/10/22 | 29/03/23 | 28/04/23 | 30/08/23 | 30/10/23 | 28/03/24 | - | - | - | - |
More events
Past sector events for Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
| Today | SANDOZ GROUP AG: Q1 2024 Sales and Revenue Release |
| 03/05/2024 | HANMI SCIENCE CO., LTD.: Q1 2024 Earnings Release |
| 02/05/2024 08:04 pm | PROCTER & GAMBLE HEALTH LIMITED: Q3 2024 Earnings Release |
| 02/05/2024 04:39 pm | AJANTA PHARMA LIMITED: Q4 2024 Earnings Release |
| 30/04/2024 | SINOTHERAPEUTICS INC.: Q4 2023 Earnings Release |
| 30/04/2024 | KUNMING LONGJIN PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release |
| 30/04/2024 | OTSUKA HOLDINGS CO., LTD.: Q1 2024 Earnings Release |
| 30/04/2024 | YIFAN PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release |
| 30/04/2024 | BORYUNG CORPORATION: Q1 2024 Earnings Release |
| 30/04/2024 | HANMI PHARM. CO., LTD.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- 002399 Stock
- Calendar Shenzhen Hepalink Pharmaceutical Group Co., Ltd.